Vagal blocking improves glycemic control and elevated blood pressure in obese subjects with type 2 diabetes mellitus

Journal of Obesity

Volumn 2013, Issue , 2013, Pages

  Shikora, S ^a   Toouli, J ^b   Herrera, M F ^c   Kulseng, B ^d   Zulewski, H ^e   Brancatisano, R ^f   Kow, L ^b   Pantoja, J P ^c   Johnsen, G ^d   Brancatisano, A ^f   Tweden, K S ^g   Knudson, M B ^g   Billington, C J ^h  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b Flinders Private Hospital   (Australia)

^c INSTITUTO NACIONAL DE CIENCIAS MÉDICAS Y NUTRICIÓN SALVADOR ZUBIRÁN   (Mexico)

^d TRONDHEIM UNIVERSITY HOSPITAL   (Norway)

^e UNIVERSITY HOSPITAL BASEL   (Switzerland)

^f Institute of Weight Control   (Australia)

^g EnteroMedics Inc   (United States)

^h UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BLOOD PRESSURE; CLINICAL ARTICLE; CONTROLLED STUDY; DEVICE SAFETY; FEASIBILITY STUDY; FEMALE; GLYCEMIC CONTROL; HUMAN; HYPERTENSION; INTERMITTENT VAGAL BLOCKING; MALE; MEAN ARTERIAL PRESSURE; NERVE BLOCK; NEUROLOGICAL THERAPEUTIC DEVICE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; OPEN STUDY; PRIORITY JOURNAL; VAGUS NERVE; WEIGHT REDUCTION; AUSTRALIA; BLOOD; CLINICAL TRIAL; EQUIPMENT; GLUCOSE BLOOD LEVEL; METABOLISM; MEXICO; MIDDLE AGED; MULTICENTER STUDY; NORWAY; PATHOPHYSIOLOGY; PROSPECTIVE STUDY; TREATMENT OUTCOME; VAGOTOMY; COMPLICATION; DEVICES; DIABETES MELLITUS, TYPE 2;

BIOLOGICAL MARKER; GLYCOSYLATED HEMOGLOBIN; HEMOGLOBIN A1C PROTEIN, HUMAN; GLUCOSE BLOOD LEVEL;

AUSTRALIA; BIOLOGICAL MARKERS; BLOOD GLUCOSE; BLOOD PRESSURE; DIABETES MELLITUS, TYPE 2; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPERTENSION; MALE; MEXICO; MIDDLE AGED; NORWAY; OBESITY; PROSPECTIVE STUDIES; TREATMENT OUTCOME; VAGOTOMY; VAGUS NERVE; WEIGHT LOSS;

EID: 84883199443     PISSN: 20900708     EISSN: 20900716     Source Type: Journal    
DOI: 10.1155/2013/245683     Document Type: Article

References (34)

1. Wild S., Roglic G., Green A., Sicree R., King H., Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 2004 27 5 1047 1053 2-s2.0-2342466734 10.2337/diacare.27.5.1047
2. Danaei G., Finucane M. M., Lu Y., Singh G. M., Cowan M. J., Paciorek C. J., Lin J. K., Farzadfar F., Khang Y. H., Stevens G. A., Rao M., Ali M. K., Riley L. M., Robinson C. A., Ezzati M., National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2 · 7 million participants. The Lancet 2011 378 9785 31 40 2-s2.0-79959936188 10.1016/S0140-6736(11)60679-X
3. Maggio C. A., Pi-Sunyer F. X., The prevention and treatment of obesity: application to type 2 diabetes. Diabetes Care 1997 20 11 1744 1766 2-s2.0-0030778116
4. Must A., Spadano J., Coakley E. H., Field A. E., Colditz G., Dietz W. H., The disease burden associated with overweight and obesity. Journal of the American Medical Association 1999 282 16 1523 1529 2-s2.0-0032742418 10.1001/jama.282.16.1523
5. Fujioka K., Benefits of moderate weight loss in patients with type 2 diabetes. Diabetes, Obesity and Metabolism 2010 12 3 186 194 2-s2.0-75649088159 10.1111/j.1463-1326.2009.01155.x
6. Mingrone G., Panunzi S., De Gaetano A., Guidone C., Iaconelli A., Leccesi L., Bariatric surgery versus conventional medical therapy for type 2 diabetes. The New England Journal of Medicine 2012 366 1577 1585
7. Schauer P. R., Kashyap S. R., Wolski K., Brethauer S. A., Kirwan J. P., Pothier C. E., Bariatric surgery versus intensive medical therapy in obese patients with diabetes. The New England Journal of Medicine 2012 366 1567 1576
8. Guyton A. C., Hall J. E., Textbook of Medical Physiology 2000 10th St. Louis, Mo, USA W.B. Saunders Company
9. Pardo J. V., Sheikh S. A., Schwindt G. C., Lee J. T., Kuskowski M. A., Surerus C., Lewis S. M., Abuzzahab F. S., Adson D. E., Rittberg B. R., Chronic vagus nerve stimulation for treatment-resistant depression decreases resting ventromedial prefrontal glucose metabolism. NeuroImage 2008 42 2 879 889 2-s2.0-47949111241 10.1016/j.neuroimage.2008.04.267
10. Kral J. G., Paez W., Wolfe B. M., Vagal nerve function in obesity: therapeutic implications. World Journal of Surgery 2009 33 10 1995 2006 2-s2.0-70349314685 10.1007/s00268-009-0138-8
11. Camilleri M., Toouli J., Herrera M. F., Kow L., Pantoja J. P., Billington C. J., Selection of electrical algorithms to treat obesity with intermittent vagal block using an implantable medical device. Surgery for Obesity and Related Diseases 2009 5 224 230
12. Camilleri M., Toouli J., Herrera M. F., Kulseng B., Kow L., Pantoja J. P., Marvik R., Johnsen G., Billington C. J., Moody F. G., Knudson M. B., Tweden K. S., Vollmer M., Wilson R. R., Anvari M., Intra-abdominal vagal blocking (VBLOC therapy): clinical results with a new implantable medical device. Surgery 2008 143 6 723 731 2-s2.0-44749089237 10.1016/j.surg.2008.03.015
13. Tweden K. S., Sarr M. G., Bierk M. D., Camilleri M., Kendrick M. L., Knudson M. B., Vagal blocking for obesity control (VBLOC): studies of pancreatic and gastric function and safety in a porcine model. Surgery For Obesity and Related Diseases 2006 2 3 301 302
14. Herrera M. F., Brancatisano R., Keller U., Kulseng B., Toouli J., Brancatisano A., Intermittent vagal blockade with an implantable device improves glycemic control in obese subjects with type 2 diabetes. Surgery For Obesity and Related Diseases 2009 5 Supplement 3 S48 S49
15. Herrera M. F., Kow L., Pantoja J. P., Knudson M. B., Tweden K. S., Wilson R. R., VBLOC and improvements in co-morbidities in obese subjects during weight loss. Obesity Surgery 2009 19 983 984
16. Tweden K. S., Anvari M., Bierk M. D., Billington C. J., Camilleri M., Honda C. N., Vagal blocking for obesity control (VBLOC): concordance of effects of very high frequency vagal blocking currents at the neural and organ levels using two pre-clinical models. Gastroenterology 2006 130 Supplement 2 148
17. Pickering T. G., Hall J. E., Appel L. J., Falkner B. E., Graves J., Hill M. N., Jones D. W., Kurtz T., Sheps S. G., Roccella E. J., Recommendations for blood pressure measurement in humans and experimental animals: part 1: blood pressure measurement in humans. Circulation 2005 111 5 697 716 2-s2.0-13444255966
18. The seventh report of the Joint National Committee on the prevention, detection, evaluation, and treatment of high blood pressure (JNC-7). Publication no. 2003 03-5233 Bethesda, Md, USA National Institutes of Health (US)
19. Bray G. A., Bouchard C., Church T. S., Cefalu W. T., Greenway F. L., Gupta A. K., Kaplan L. M., Ravussin E., Smith S. R., Ryan D. H., Is it time to change the way we report and discuss weight loss? Obesity 2009 17 4 619 621 2-s2.0-63049101370 10.1038/oby.2008.597
20. Fryar C. D., Carroll M. D., Ogden C. L., Prevalence of overweight and obesity among adults: United States, trends 1960-1962 through 2009-2010 (Health E-Stat). Hyattsville (MD): National Center for Health Statistics (US), 2012, http://www.cdc.gov/nchs/data/hestat/obese/obese99.htm
21. Hubert H. B., Feinleib M., McNamara P. M., Castelli W. P., Obesity as an independent risk factor for cardiovascular disease: a 26-year follow-up of participants in the Framingham Heart Study. Circulation 1983 67 5 968 977 2-s2.0-0020533259
22. Lew E. A., Garfinkel L., Variations in mortality by weight among 750,000 men and women. Journal of Chronic Diseases 1979 32 8 563 576 2-s2.0-0018646411
23. Dixon J. B., O'Brien P. E., Playfair J., Chapman L., Schachter L. M., Skinner S., Proietto J., Bailey M., Anderson M., Adjustable gastric banding and conventional therapy for type 2 diabetes: a randomized controlled trial. Journal of the American Medical Association 2008 299 3 316 323 2-s2.0-38349136266 10.1001/jama.299.3.316
24. Schauer P. R., Burguera B., Ikramuddin S., Cottam D., Gourash W., Hamad G., Eid G. M., Mattar S., Ramanathan R., Barinas-Mitchel E., Rao R. H., Kuller L., Kelley D., Saar M. G., Meguid M. A., Buchwald H., Effect of laparoscopic Roux-En Y gastric bypass on type 2 diabetes mellitus. Annals of Surgery 2003 238 4 467 485 2-s2.0-10744222607
25. Wing R. R., Bahnson J. L., Bray G. A., Clark J. M., Coday M., Egan C., Espeland M. A., Foreyt J. P., Gregg E. W., Goldman V., Haffner S. M., Hazuda H., Hill J. O., Horton E. S., Hubbard V. S., Jakicic J., Jeffery R. W., Johnson K. C., Kahn S., Killean T., Kitabchi A. E., Lewis C. E., Manus C., Maschak-Carey B. J., Michaels S., Montez M., Montgomery B., Nathan D. M., Patricio J., Peters A., Pi-Sunyer X., Pownall H., Reboussin D., Rejeski W. J., Rubin R., Safford M., Skarphol T., Van Dorsten B., Wadden T. A., Wagenknecht L., Wesche-Thobaben J., West D. S., Williamson D., Yanovski S. Z., Long-term effects of a lifestyle intervention on weight and cardiovascular risk factors in individuals with type 2 diabetes mellitus: four-year results of the look AHEAD trial. Archives of Internal Medicine 2010 170 17 1566 1575 2-s2.0-77957690115 10.1001/ archinternmed.2010.334
26. Fujioka K., Seaton T. B., Rowe E., Jelinek C. A., Raskin P., Lebovitz H. E., Weinstein S. P., Weight loss with sibutramine improves glycaemic control and other metabolic parameters in obese patients with type 2 diabetes mellitus. Diabetes, Obesity and Metabolism 2000 2 3 175 187 2-s2.0-0034522392 10.1046/j.1463-1326.2000.00081.x
27. Elder K. A., Wolfe B. M., Bariatric surgery: a review of procedures and outcomes. Gastroenterology 2007 132 6 2253 2271 2-s2.0-34247846358 10.1053/j.gastro.2007.03.057
28. Scopinaro N., Papadia F., Camerini G., Marinari G., Civalleri D., Franco A. G., A comparison of a personal series of biliopancreatic diversion and literature data on gastric bypass help to explain the mechanisms of resolution of type 2 diabetes by the two operations. Obesity Surgery 2008 18 8 1035 1038 2-s2.0-48749107098 10.1007/s11695-008-9531-x
29. Korner J., Bessler M., Inabnet W., Taveras C., Holst J. J., Exaggerated glucagon-like peptide-1 and blunted glucose-dependent insulinotropic peptide secretion are associated with Roux-en-Y gastric bypass but not adjustable gastric banding. Surgery for Obesity and Related Diseases 2007 3 6 597 601 2-s2.0-36048950771 10.1016/j.soard.2007.08.004
30. Patriti A., Facchiano E., Sanna A., Gullà N., Donini A., The enteroinsular axis and the recovery from type 2 diabetes after bariatric surgery. Obesity Surgery 2004 14 6 840 848 2-s2.0-3242814564 10.1381/0960892041590818
31. Bose M., Oliván B., Teixeira J., Pi-Sunyer F. X., Laferrère B., Do incretins play a role in the remission of type 2 diabetes after gastric bypass surgery: what are the evidence? Obesity Surgery 2009 19 2 217 229 2-s2.0-58649086097 10.1007/s11695-008-9696-3
32. Bernal-Mizrachi C., Xiaozhong L., Yin L., Knutsen R. H., Howard M. J., Arends J. J. A., DeSantis P., Coleman T., Semenkovich C. F., An afferent vagal nerve pathway links hepatic PPAR α activation to glucocorticoid-induced insulin resistance and hypertension. Cell Metabolism 2007 5 2 91 102 2-s2.0-33846622807 10.1016/j.cmet.2006.12.010
33. Shikora S. A., Bergenstal R., Bessler M., Brody F., Foster G., Frank A., Gold M., Klein S., Kushner R., Sarwer D. B., Implantable gastric stimulation for the treatment of clinically severe obesity: results of the SHAPE trial. Surgery for Obesity and Related Diseases 2009 5 1 31 37 2-s2.0-58249089270 10.1016/j.soard.2008.09.012
34. Dansinger M. L., Tatsioni A., Wong J. B., Chung M., Balk E. M., Meta-analysis: the effect of dietary counseling for weight loss. Annals of Internal Medicine 2007 147 1 41 50 2-s2.0-34447290920